Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-CHLORO-2-ETHOXY-3-FLUORO-PYRIDINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

886373-94-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 886373-94-0 Structure
  • Basic information

    1. Product Name: 5-CHLORO-2-ETHOXY-3-FLUORO-PYRIDINE
    2. Synonyms: 5-CHLORO-2-ETHOXY-3-FLUORO-PYRIDINE
    3. CAS NO:886373-94-0
    4. Molecular Formula: C7H7ClFNO
    5. Molecular Weight: 175.5879832
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 886373-94-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C
    8. Solubility: N/A
    9. CAS DataBase Reference: 5-CHLORO-2-ETHOXY-3-FLUORO-PYRIDINE(CAS DataBase Reference)
    10. NIST Chemistry Reference: 5-CHLORO-2-ETHOXY-3-FLUORO-PYRIDINE(886373-94-0)
    11. EPA Substance Registry System: 5-CHLORO-2-ETHOXY-3-FLUORO-PYRIDINE(886373-94-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 886373-94-0(Hazardous Substances Data)

886373-94-0 Usage

Uses

5-Chloro-2-ethoxy-3-fluoropyridine

Check Digit Verification of cas no

The CAS Registry Mumber 886373-94-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,3,7 and 3 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 886373-94:
(8*8)+(7*8)+(6*6)+(5*3)+(4*7)+(3*3)+(2*9)+(1*4)=230
230 % 10 = 0
So 886373-94-0 is a valid CAS Registry Number.

886373-94-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Chloro-2-ethoxy-3-fluoropyridine

1.2 Other means of identification

Product number -
Other names 5-chloro-2-ethoxy-3-fluoropyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:886373-94-0 SDS

886373-94-0Relevant articles and documents

IMIDAZO[1,2-a]PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES

-

Page/Page column 42, (2013/02/28)

The present invention relates to novel imidazo[1,2-a]pyrazine derivatives which are inhibitors of the phosphodiesterase 10 enzyme (PDE10) and which are useful for the treatment or prevention of neurological, psychiatric and metabolic disorders in which the PDE10 enzyme is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, to the use of such compounds or pharmaceutical compositions for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases.

IMIDAZO [1, 2 -A] PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES

-

Page/Page column 88, (2011/10/05)

The present invention relates to novel imidazo[1,2-a]pyrazine derivatives which are inhibitors of the phosphodiesterase 10 enzyme (PDE10) and which are useful for the treatment or prevention of neurological, psychiatric and metabolic disorders in which the PDE10 enzyme is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, to the use of such compounds or pharmaceutical compositions for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 886373-94-0